Hypopituitarism findings in patients with primary brain tumors 1 year neurosurgical treatment: Preliminary report

Journal of Endocrinological Investigation

Volumn 29, Issue 6, 2006, Pages 516-522

  De Marinis, Laura ^a   Fusco, A ^a   Bianchi, A ^a   Aimaretti, G ^b   Ambrosio, M R ^c   Scaroni, C ^d   Cannavo, S ^e   Di Somma, C ^f   Mantero, F ^d   degli Uberti, E C ^c   Giordano, G ^g   Ghigo, E ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e UNIVERSITY OF MESSINA   (Italy)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^g Italilna Society of Endocrinology   (Italy)

Author keywords

GH deficiency; Hypopituitarism; Neurosurgery; Primary brain tumors; Vascular factor

Indexed keywords

ARGININE; CORTICOSTEROID; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; SEX HORMONE; SOMATOMEDIN C; THYROID HORMONE;

ADRENAL CORTEX INSUFFICIENCY; ADULT; AGED; ARTICLE; BENIGN TUMOR; BODY MASS; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPERPROLACTINEMIA; HYPOGONADISM; HYPOPHYSIS FUNCTION; HYPOPITUITARISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHYROIDISM; MALE; NEUROGENIC DIABETES INSIPIDUS; NEUROSURGERY; POSTOPERATIVE PERIOD; SELLA TURCICA; TUMOR LOCALIZATION; VALIDATION STUDY;

EID: 33746706890     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03344141     Document Type: Article

References (27)

1. Smith JC. Hormone replacement therapy in hypopituitarism. Expert Opin Pharmacother 2004, 5:1023-31.
2. Aimaretti G, Ambrosio MR, Di Somma C, et al. Traumatic brain injury and subarhacnoid haemorrhage are condition at high risk for hypopituitarism: screening study at 3 months after the brain injury. Clin Endocrinol (Oxf) 2004, 61: 320-6.
3. Darzi KH, Shalet SM. Radiation-induced growth hormone deficiency. Horm Res 2003, 59 (Suppl 1): 1-11.
4. Ilveskoski I, Saarinen T, Wiklund T, et al. Growth impairment and growth hormone therapy in children treated for malignant brain tumors. Eur J Pediatr 1997, 156: 764-9.
5. Brauner R, Adan L, Souberbielle JC. Hypothalamic-pituitary function and growth in children with intracranial lesions. Child's Nerv Syst 1999, 15: 662-9.
6. Toogood AA. Endocrine consequences of brain irradiation. Growth Horm IGF Res 2004, 14 (Suppl A): S118-24.
7. Aimaretti G, Ambrosio MR, Benvenga S, et al. Hypopituitarism and growth hormone deficiency (GHD) after traumatic brain injury (TBI). Growth Horm IGF Res 2004, 14 (Suppl A): S114-7.
8. Altinors N, Caner H, Bavbek M, et al. Problems in management of intracranial meningiomas. J Invest Surg 2004, 17: 283-9.
9. McMullen KP, Stieber VW. Meningioma: current treatment options and future directions. Curr Treat Options Oncol 2004, 5: 499-509.
10. Stieber VW. Low-grade gliomas. Curr Treat Options Oncol 2001, 2: 495-506.
11. Whittle IR. Surgery for gliomas. Curr Opin Neurol 2002, 15: 663-9.
12. Dumont AS, Farace E, Schiff D, Shaffrey ME. Intraventricular gliomas. Neurosurg Clin N Am 2003, 14: 571-91.
13. Schmidt MH, Gottfried ON, von Hoch CS, Chang SM, McDermott MW. Central neurocytoma: a review. J Neurooncol 2004, 66: 377-84.
14. Drummond KJ, Zhu JJ, Black PM. Meningiomas: updating basic science, management and outcome. Neurologist 2004, 10: 113-30.
15. Ghigo E, Aimaretti G, Arvat E, Camanni F. Growth hormone-releasing hormone combined with arginine or growth hormone secretagogues for the diagnosis of growth hormone deficiency in adults. Endocrine 2001, 15: 29-38.
16. Lamberts SWJ, de Herder WW, van der Lely AJ. Pituitary insufficiency. Lancet 1998, 352: 127-34.
17. Lissett CA, Shalet SM. Hypopituitarism. In: DeGroot LJ, Jameson JL eds. Endocrinology. 4th ed. W.B. Saunders Company, Philadelphia.
18. Thorner MO, Vance ML, Laws Jr ER, Horvath E, Kovacs K. The Anterior pituitary. In: Wilson JD, Foster DW, Kronenberg HM eds. Williams Textbook of Endocrinology. 9th ed. Philadelphia: W.B. Saunders Company. 1998, 165.
19. Faglia G. Clinical Aspects of the pituitary gland. In: Pinchera A ed. Endocrinology and Metabolism. London: McGraw-Hill Int. 2001.
20. Aimaretti G, Corneli G, Razzone P, et al. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults. J Clin Endocrinol Metab 1998, 83: 1615-8.
21. Hartman ML, Crowe BJ, Biller BM, et al. U.S. HypoCCS Study Group. Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? J Clin Endocrinol Metab 2002, 87: 477-85.
22. Nakajima W, Ishida A, Lange M, et al. Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat. J Neurosci 2000, 20: 7994-8004.
23. Scott RJ, Hegyi L. Cell death in perinatal hypoxic-ischaemic brain injury. Neuropathol Appl Neurobiol 1997, 23: 307-14.
24. Stroemer RP, Rothwell NJ. Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1β in the rat. J Cereb Blood Flow Metab 1998, 18: 833-39.
25. Popovic V, Pekic S, Pavlovic D, et al. Hypopituitarism as a consequence of traumatic brain injury (TBI) and its possible relation with cognitive disabilities and mental distress. J Endocrinol Invest 2004, 27: 1048-54.
26. Aimaretti G, Corneli G, Rovere S, et al. Insulin-like growth factor I levels and the diagnosis of adult growth hormone deficiency. Horm Res 2004, 62 (Suppl 1): 26-33.
27. Agha A, Sherlock M, Brennan S, et al. Hypothalamic-pituitary dysfunction following irradiation of non-pituitary brain tumors in adults. J Clin Endocrinol Metab 2005, 90: 6355-60.